ONO 1078

Known as: ONO-1078 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-2017
051019872017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
AIM To determine whether ONO-1078 [pranlukast, 4-oxo-8-[p-(4-phenylbutyloxy)benzoyl-amono]-2-(tetrazol-5-yl)-4H-1-benzopyran… (More)
  • figure 1
  • figure 2
Is this relevant?
2002
2002
AIM To determine whether ONO-1078 (pranlukast), a potent leukotriene receptor antagonist, has neuroprotective effect on focal… (More)
Is this relevant?
2001
2001
AIM To determine whether ONO-1078 [pranlukast, 4-oxo-8-[p-(4-phenylbutyloxy) benzoyl-amino]-2-(tetrazol-5-yl)-4H-1-benzopyran… (More)
Is this relevant?
1999
1999
BACKGROUND ONO-1078 (pranlukast) is a leukotriene receptor antagonist developed in Japan. This drug has been shown to be useful… (More)
Is this relevant?
1994
1994
We evaluated the effect of ONO-1078, a selective leukotriene-C4, -D4, and -E4-receptor antagonist, on bronchoconstriction… (More)
Is this relevant?
1994
1994
The role of lipoxygenase metabolites in the pathogenesis of endotoxin (LPS)-induced lung injury remains to be clarified. We… (More)
Is this relevant?
1993
1993
BACKGROUND Cysteinyl leukotrienes are potent contractile agonists for airway smooth muscle. To examine the relative role of… (More)
Is this relevant?
1993
1993
To evaluate the involvement of sulphidopeptide leukotrienes on bronchial hyperresponsiveness in asthma, we examined the effects… (More)
Is this relevant?
1992
1992
We evaluated the antagonist activity of ONO-1078 against peptide leukotrienes (LTs) by a radioligand binding assay and functional… (More)
Is this relevant?
1992
1992
We investigated the in vivo antagonistic activity of ONO-1078 against peptide leukotrienes (LTs) in guinea pigs. ONO-1078, when… (More)
Is this relevant?